EORTC CLTF 2018 | ECP for cutaneous lymphoma: current landscape & first prospective trial
Extracorporeal photopheresis (ECP) is a non-surgical procedure currently indicated for the treatment of graft-versus-host disease; however, retrospective analyses have shown that ECP is a useful therapy for cutaneous T-cell lymphoma (CTCL). Here, Robert Knobler, MD, of the Medical University of Vienna, Vienna, Austria, discusses the utilization and benefits of ECP for CTCL, and highlights the upcoming European Organisation for the Research and Treatment of Cancer (EORTC) prospective study investigating the use of ECP in this indication (PROMPT; NCT03563040). This video was recorded at the EORTC Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
Get great new content delivered to your inboxSign up